StockData
NUMDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Nu-Med Plus, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026

Market cap
$601.55K
P/E (TTM)
–
Dividend yield
–

Nu-Med Plus, Inc. revenue by segment

No segment breakdown reported

Nu-Med Plus does not break out revenue by segment, region or product in the tagged data of its filings for this period type.